lidocaine has been researched along with Pelvic Pain in 25 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A novel cognitive-behavioral couple therapy (CBCT) has shown efficacy for treating provoked vestibulodynia (PVD), the most common type of genito-pelvic pain, in comparison to topical lidocaine." | 5.69 | Mediators of change in cognitive-behavioral couple therapy for genito-pelvic pain: Results of a randomized clinical trial. ( Bergeron, S; Corsini-Munt, S; Mayrand, MH; Rosen, NO; Santerre-Baillargeon, M; Steben, M; Vaillancourt-Morel, MP, 2023) |
| "To determine if a novel, magnesium-based trigger point infiltration formulation is more effective in treating chronic myofascial pelvic pain than lidocaine-only infiltration." | 5.51 | Magnesium-Based Trigger Point Infiltrations Versus Local Anaesthetic Infiltrations in Chronic Pelvic Myofascial Pain: A Randomized, Double-Blind, Controlled Study. ( Chamberlain, S; Henry, R; Leitch, J; Nitsch, R; Pudwell, J; Webb, A, 2022) |
| "Two phase 2 studies were conducted to assess the efficacy and safety of lidocaine-releasing intravesical system (LiRIS) in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with (Study 001; NCT02395042) or without, (Study 002; NCT02411110) Hunner lesions (HL)." | 5.41 | Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions. ( Evans, R; Geib, T; Kohan, A; Moldwin, R; Peters, KM; Radecki, D, 2021) |
| "Lidocaine injection seems to be better for reducing the severity of chronic pelvic pain secondary to abdominal wall trigger points compared to ischemic compression via physical therapy." | 5.20 | Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain. ( Braz, CA; Candido-dos-Reis, FJ; Montenegro, ML; Nogueira, AA; Poli-Neto, OB; Rosa-e-Silva, JC, 2015) |
| "Lidocaine was injected along the spinal process of the painful segment in the supra- and interspinal ligaments using a 25G X 2" needle." | 2.80 | Efficacy of paraspinal anesthetic block in patients with chronic pelvic pain refractory to drug therapy: a randomized clinical trial. ( Amantéa, VA; da Rosa, KF; dos Santos, AC; Savaris, RF, 2015) |
| "Pelvic pain was assessed, with a 100 mm visual analogue scale, at 1 hour, at hospital discharge, and time of first analgesia or any other time analgesia was demanded." | 2.68 | Local anaesthetic on Filshie clips for pain relief after tubal sterilisation: a randomised double-blind controlled trial. ( Breeson, AJ; Ezeh, UO; Lamb, MD; Martin, JL; Shoulder, VS; Vellacott, ID, 1995) |
| "Pelvic pain was detected 5 days after antigen instillation and was sustained beyond 30 days, indicating the development of chronic pain." | 1.35 | Experimental autoimmune prostatitis induces chronic pelvic pain. ( Rudick, CN; Schaeffer, AJ; Thumbikat, P, 2008) |
| "Pelvic pain was assessed using von Frey filament stimulation to the pelvic region, and mice infected with PRV developed progressive pelvic pain." | 1.34 | Organ cross talk modulates pelvic pain. ( Chen, MC; Klumpp, DJ; Mongiu, AK; Rudick, CN, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leitch, J | 1 |
| Webb, A | 1 |
| Pudwell, J | 1 |
| Chamberlain, S | 1 |
| Henry, R | 1 |
| Nitsch, R | 1 |
| Santerre-Baillargeon, M | 1 |
| Rosen, NO | 1 |
| Vaillancourt-Morel, MP | 1 |
| Corsini-Munt, S | 1 |
| Steben, M | 1 |
| Mayrand, MH | 1 |
| Bergeron, S | 1 |
| Hui, J | 1 |
| Seko, K | 1 |
| Shrikhande, G | 1 |
| Ahmed, T | 1 |
| Hill, C | 1 |
| Reutter, C | 1 |
| Shrikhande, A | 1 |
| Li, T | 1 |
| Feng, XY | 1 |
| Feng, XM | 1 |
| Lv, JW | 1 |
| Lv, TT | 1 |
| Wang, SY | 1 |
| Evans, R | 1 |
| Kohan, A | 1 |
| Moldwin, R | 1 |
| Radecki, D | 1 |
| Geib, T | 1 |
| Peters, KM | 1 |
| Elkhouly, NI | 1 |
| Maher, MA | 1 |
| Wickström, K | 1 |
| Edelstam, G | 1 |
| Akers, AY | 1 |
| Steinway, C | 1 |
| Sonalkar, S | 1 |
| Perriera, LK | 1 |
| Schreiber, C | 1 |
| Harding, J | 1 |
| Garcia-Espana, JF | 1 |
| Poli-Neto, OB | 2 |
| Campos Martins Chamochumbi, C | 1 |
| Toscano, P | 1 |
| Pitanguy Julio, M | 1 |
| Marques, W | 1 |
| Rosa-E-Silva, JC | 2 |
| Candido-Dos-Reis, FJ | 2 |
| Nogueira, AA | 2 |
| Torstensson, T | 1 |
| Lindgren, A | 1 |
| Kristiansson, P | 1 |
| Kim, SH | 1 |
| Kim, DH | 1 |
| Yoon, DM | 1 |
| Yoon, KB | 1 |
| da Rosa, KF | 1 |
| Amantéa, VA | 1 |
| dos Santos, AC | 1 |
| Savaris, RF | 1 |
| Montenegro, ML | 1 |
| Braz, CA | 1 |
| Pillai, M | 1 |
| Shefras, J | 1 |
| Piroli, A | 1 |
| Marci, R | 1 |
| Marinangeli, F | 1 |
| Paladini, A | 1 |
| Di Emidio, G | 1 |
| Giovanni Artini, P | 1 |
| Caserta, D | 1 |
| Tatone, C | 1 |
| Mody, SK | 1 |
| Kiley, J | 1 |
| Rademaker, A | 1 |
| Gawron, L | 1 |
| Stika, C | 1 |
| Hammond, C | 1 |
| Kim, DS | 1 |
| Jeong, TY | 1 |
| Kim, YK | 1 |
| Chang, WH | 1 |
| Yoon, JG | 1 |
| Lee, SC | 1 |
| Parsons, CL | 1 |
| Bonnin, M | 1 |
| Bolandard, F | 1 |
| Storme, B | 1 |
| Sibaud, F | 1 |
| Rabishong, B | 1 |
| Langford, CF | 1 |
| Udvari Nagy, S | 1 |
| Ghoniem, GM | 1 |
| Käll, E | 1 |
| Lindström, E | 1 |
| Martinez, V | 1 |
| Rudick, CN | 2 |
| Chen, MC | 1 |
| Mongiu, AK | 1 |
| Klumpp, DJ | 1 |
| Schaeffer, AJ | 1 |
| Thumbikat, P | 1 |
| Ezeh, UO | 1 |
| Shoulder, VS | 1 |
| Martin, JL | 1 |
| Breeson, AJ | 1 |
| Lamb, MD | 1 |
| Vellacott, ID | 1 |
| Davies, A | 1 |
| Richardson, RE | 1 |
| O'Connor, H | 1 |
| Baskett, TF | 1 |
| Nagele, F | 1 |
| Magos, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Control Trial of Magnesium-Based Trigger Point Injections vs. Lidocaine-Only Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain[NCT02728037] | Phase 3 | 38 participants (Actual) | Interventional | 2016-04-30 | Terminated (stopped due to Low Enrollment, Adoption of investigational treatment into standard practice at our center.) | ||
| Clinical Effect Observation for Electrical Pudendal Nerve Stimulation in Treating Urethral Pain Syndrome[NCT03671993] | 50 participants (Actual) | Interventional | 2018-10-05 | Completed | |||
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome[NCT02411110] | Phase 2 | 131 participants (Actual) | Interventional | 2015-05-21 | Completed | ||
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions[NCT02395042] | Phase 2 | 59 participants (Actual) | Interventional | 2015-04-15 | Completed | ||
| Comparison of the Effects of Yoga and Aerobic Exercise Training in Primary Dysmenorrhea[NCT05623085] | 44 participants (Anticipated) | Interventional | 2022-01-10 | Recruiting | |||
| Pertubation With Lignocaine in Endometriosis Associated Symptoms Effect Study[NCT01329796] | Phase 2 | 42 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| Comparison of the Effects of Pain Neuroscience Education and Biomedical Pain Education in Primary Dysmenorrhea[NCT06040866] | 38 participants (Anticipated) | Interventional | 2022-12-09 | Recruiting | |||
| Lidocaine for Pain Control During Intrauterine Device Insertion: A Randomized Clinical Trial[NCT03362905] | Phase 4 | 123 participants (Anticipated) | Interventional | 2017-12-03 | Not yet recruiting | ||
| Music to Reduce Patient Reported Pain During Intrauterine Device (IUD) Placement in the Office[NCT05068245] | 96 participants (Actual) | Interventional | 2020-08-28 | Completed | |||
| Study of Pain Control With Hormonal IUS Insertion (SOPHI Study)[NCT02352714] | Phase 4 | 98 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| Injection Treatment of Slow-Release Corticosteroid to the Sacrospinous Ligament Insertions on Women With Long-Lasting Low Back Pain Starting in Pregnancy.[NCT00757016] | 38 participants (Actual) | Interventional | 2004-10-31 | Completed | |||
| Efficacy of Paraspinous Anesthetic Block in Patients With Chronic Pelvic Pain Non-Responsive to Pharmacological Treatment[NCT01635205] | Phase 4 | 60 participants (Anticipated) | Interventional | 2011-10-31 | Completed | ||
| Local Injection of Lidocaine Versus Ischemic Compression in Treatment of Woman With Chronic Pelvic Pain Caused by Abdominal Myofascial Pain Syndrome: Randomized Clinical Trial.[NCT00628355] | Phase 4 | 30 participants (Actual) | Interventional | 2008-02-29 | Terminated (stopped due to Lidocaine injection group showed significant improvement in pain) | ||
| A Comparison of Two Different Anesthetic Application (Sedation / Analgesia & LMA) on Anxiety Level and Patient Satisfaction in Patients With in Vitro Fertilization: Prospective Randomized Clinical Trial[NCT03814330] | 140 participants (Actual) | Interventional | 2019-01-24 | Completed | |||
| Assessment Of Pain Subsidence And Sexual Function Amelioration Using Either Pelvic Rehabilitation Or Trigger Point Injections[NCT02022722] | Phase 4 | 36 participants (Anticipated) | Interventional | 2013-08-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The participant recorded their bladder pain over the previous 24-hour period in a 7-day pain assessment tool using an 11-point Numeric Rating Scale (NRS) (0 to 10) where 0=no pain to 10= worst pain. Pain data recorded over the 7-day period were averaged. A negative change from Baseline indicates improvement. An Analysis of Covariance (ANCOVA) model with baseline value as a covariate and treatment group and stratification factors (age group: < 40 years or ≥ 40 years and baseline bladder pain NRS: ≤ 6 or > 6) as factors was used for analysis. (NCT02411110)
Timeframe: Baseline (Days -7 to 0) to Treatment 1 Week 4
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| LiRIS® (Treatment Period 1) | -1.2 |
| LiRIS Placebo (Treatment Period 1) | -1.5 |
The participant recorded their daily bladder pain score over the previous 24-hour period on a 7-day pain assessment tool as measured by an NRS on an 11-point scale where 0=no pain to 10=worst pain imaginable. The daily pain scores over the 7-day period were averaged. A negative change from Baseline indicates improvement. An analysis of covariance (ANCOVA) model with Baseline value as a covariate and treatment group and stratification (baseline bladder pain NRS: ≤ 5 or > 5) as factors was used for analysis. (NCT02395042)
Timeframe: Baseline (Day -7 to Day 0) to Week 4
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| LiRIS Placebo, LiRIS Placebo (Tx 1)/LiRIS® (Tx 2) | -1.6 |
| LiRIS®, LiRIS® (Tx 1)/LiRIS® (Tx 2) | -2.7 |
| LiRIS Placebo, LiRIS® (Tx 1)/ LiRIS® (Tx 2) | -2.5 |
During each cystoscopy, the investigator counted the number of lesions visible while performing the bladder scan. A negative change from Baseline indicates improvement (less lesions). An ANCOVA model with Baseline value as a covariate and treatment group and stratification (baseline bladder pain NRS: ≤ 5 or > 5) as factors was used for analysis. (NCT02395042)
Timeframe: Baseline (Day 0) to Week 4
| Intervention | Hunner's lesions (Least Squares Mean) |
|---|---|
| LiRIS Placebo, LiRIS Placebo (Tx 1)/LiRIS® (Tx 2) | 0.8 |
| LiRIS®, LiRIS® (Tx 1)/LiRIS® (Tx 2) | -0.6 |
| LiRIS Placebo, LiRIS® (Tx 1)/ LiRIS® (Tx 2) | -0.2 |
We analyzed the clinical response rate considering significative reduction of 50% of visual analogue scale or significative subjective improvement. (NCT00628355)
Timeframe: immediately, 1, 3 months after treatment
| Intervention | percentage of participants (Number) | ||
|---|---|---|---|
| immediately after treatment | 1 month after treatment | 3 months after treatment | |
| Anesthesia Injection | 45.3 | 60.2 | 69.9 |
| TENS Plus Ischemic Compression | 17.5 | 8.8 | 7.0 |
"The pain will measured by using the visual analogue scale, that is represented by a straight line of 100mm starting at absence of pain and ending at point worst pain experienced or imagined." (NCT00628355)
Timeframe: immediately, 1, 3 months after treatment
| Intervention | millimeters (Mean) | ||
|---|---|---|---|
| immediately after treatment | 1 month after treatment | 3 months after treatment | |
| Anesthesia Injection | 33.7 | 27.1 | 20.8 |
| Ischemic Compression | 52.7 | 53.0 | 50.8 |
1 review available for lidocaine and Pelvic Pain
| Article | Year |
|---|---|
Advances in the treatment of interstitial cystitis.
Topics: Administration, Intravesical; Analgesics, Non-Narcotic; Anesthetics, Local; Anti-Inflammatory Agents | 2006 |
16 trials available for lidocaine and Pelvic Pain
| Article | Year |
|---|---|
Magnesium-Based Trigger Point Infiltrations Versus Local Anaesthetic Infiltrations in Chronic Pelvic Myofascial Pain: A Randomized, Double-Blind, Controlled Study.
Topics: Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magnesium; Myofasc | 2022 |
Mediators of change in cognitive-behavioral couple therapy for genito-pelvic pain: Results of a randomized clinical trial.
Topics: Cognition; Cognitive Behavioral Therapy; Couples Therapy; Female; Humans; Lidocaine; Pelvic Pain | 2023 |
The short-term efficacy of electrical pudendal nerve stimulation versus intravesical instillation for the urethral pain syndrome: a randomized clinical trial.
Topics: Administration, Intravesical; Anesthetics, Local; Chronic Pain; Electric Stimulation Therapy; Female | 2021 |
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Topics: Adolescent; Adult; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Lidocaine; Pelvic Pa | 2021 |
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Topics: Adolescent; Adult; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Lidocaine; Pelvic Pa | 2021 |
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Topics: Adolescent; Adult; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Lidocaine; Pelvic Pa | 2021 |
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Topics: Adolescent; Adult; Cystitis, Interstitial; Double-Blind Method; Female; Humans; Lidocaine; Pelvic Pa | 2021 |
Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?
Topics: Adult; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Intr | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis.
Topics: Adult; Anesthetics, Local; Dysmenorrhea; Endometriosis; Female; Humans; Lidocaine; Minimal Clinicall | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women.
Topics: Adolescent; Adolescent Health Services; Anesthetics, Local; Female; Humans; Injections; Intrauterine | 2017 |
Electromyographic characterisation of abdominal wall trigger points developed after caesarean section and response to local anaesthesia: an observational study.
Topics: Abdominal Wall; Adult; Anesthesia, Local; Anesthetics, Local; Brazil; Cesarean Section; Chronic Pain | 2018 |
Improved function in women with persistent pregnancy-related pelvic pain after a single corticosteroid injection to the ischiadic spine: a randomized double-blind controlled trial.
Topics: Adrenal Cortex Hormones; Adult; Anesthetics, Local; Delayed-Action Preparations; Disability Evaluati | 2013 |
Efficacy of paraspinal anesthetic block in patients with chronic pelvic pain refractory to drug therapy: a randomized clinical trial.
Topics: Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Middle Aged; Nerve Block; Pain M | 2015 |
Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain.
Topics: Abdominal Wall; Adult; Anesthetics, Local; Chronic Pain; Female; Humans; Lidocaine; Pain Threshold; | 2015 |
Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block.
Topics: Adult; Anesthesia, Obstetrical; Anesthetics, Local; Female; Humans; Injections; Intrauterine Devices | 2012 |
Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block.
Topics: Adult; Anesthesia, Obstetrical; Anesthetics, Local; Female; Humans; Injections; Intrauterine Devices | 2012 |
Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block.
Topics: Adult; Anesthesia, Obstetrical; Anesthetics, Local; Female; Humans; Injections; Intrauterine Devices | 2012 |
Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block.
Topics: Adult; Anesthesia, Obstetrical; Anesthetics, Local; Female; Humans; Injections; Intrauterine Devices | 2012 |
Usefulness of a myofascial trigger point injection for groin pain in patients with chronic prostatitis/chronic pelvic pain syndrome: a pilot study.
Topics: Abdominal Muscles; Adult; Anesthetics, Local; Chronic Disease; Humans; Injections, Intramuscular; Li | 2013 |
Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain.
Topics: Adult; Aged; Anesthetics, Local; Anti-Inflammatory Agents; Anus Diseases; Bupivacaine; Chronic Disea | 2007 |
Local anaesthetic on Filshie clips for pain relief after tubal sterilisation: a randomised double-blind controlled trial.
Topics: Adult; Cyclizine; Diclofenac; Double-Blind Method; Female; Gels; Humans; Laparoscopy; Lidocaine; Mef | 1995 |
Lignocaine aerosol spray in outpatient hysteroscopy: a randomized double-blind placebo-controlled trial.
Topics: Adult; Aerosols; Anesthetics, Local; Cervix Uteri; Female; Humans; Hysteroscopy; Lidocaine; Middle A | 1997 |
8 other studies available for lidocaine and Pelvic Pain
| Article | Year |
|---|---|
A novel, nonopiod-based treatment approach to men with urologic chronic pelvic pain syndrome using ultrasound-guided nerve hydrodissection and pelvic floor musculature trigger point injections.
Topics: Adult; Chronic Pain; Female; Humans; Lidocaine; Male; Middle Aged; Pain Measurement; Pelvic Floor; P | 2020 |
Clinical effectiveness of the obturator externus muscle injection in chronic pelvic pain patients.
Topics: Adult; Aged; Anesthetics, Local; Chronic Pain; Contrast Media; Female; Fluoroscopy; Humans; Injectio | 2015 |
Experience with Instillagel(R) for hysterosonography and analgesia in a complex contraception clinic: a QIPP initiative.
Topics: Adult; Chlorhexidine; Contrast Media; Drug Combinations; Endometrium; Female; Humans; Intrauterine D | 2012 |
Comparison of different anaesthetic methodologies for sedation during in vitro fertilization procedures: effects on patient physiology and oocyte competence.
Topics: Adult; Anesthesia; Ectogenesis; Embryo Transfer; Female; Fertilization in Vitro; Humans; Infertility | 2012 |
[Pelvic pain by acute symphysis pubis separation after vaginal delivery].
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthetics, Local; Extracti | 2006 |
The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats.
Topics: Anesthetics, Local; Animals; Citalopram; Colon; Colonic Diseases, Functional; Compliance; Female; Li | 2007 |
Organ cross talk modulates pelvic pain.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Capsaicin; Colon; Cystitis, Interstitial; Evans Blue; | 2007 |
Experimental autoimmune prostatitis induces chronic pelvic pain.
Topics: Amines; Analgesics; Anesthetics, Local; Animals; Autoimmune Diseases; Chronic Disease; Cyclohexaneca | 2008 |